Myocardial integrated ultrasonic backscatter in patients with dilated cardiomyopathy: Prediction of response to β-blocker therapy
- 31 May 2000
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 139 (5) , 905-912
- https://doi.org/10.1016/s0002-8703(00)90024-3
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)The Lancet, 1999
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- Ultrasonic tissue characterization predicts myocardial viability in early stage of reperfused acute myocardial infarction.Circulation, 1998
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Which subgroup of patients with dilated cardiomyopathy would benefit from long-term beta-blocker therapy? A histologic viewpointJournal of the American College of Cardiology, 1993
- Ultrasonic tissue characterization with a real time integrated backscatter imaging system in normal and aging human heartsJournal of the American College of Cardiology, 1989
- Ultrasonic tissue characterization with integrated backscatter. Acute myocardial ischemia, reperfusion, and stunned myocardium in patients.Circulation, 1989
- Early identification with ultrasonic integrated backscatter of viable but stunned myocardium in dogsJournal of the American College of Cardiology, 1989
- Beneficial effects of long-term beta-blockade in congestive cardiomyopathy.Heart, 1980
- Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.Heart, 1975